Sienna+MR Long-term Uptake

Feasibility of Breast MRI After Sentinel Procedure for Breast Cancer With Superparamagnetic Tracers

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03243435

Enrollment

Registered

2017-08-09

Start date

2016-07-31

Completion date

2017-04-30

Last updated

2017-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Female

Brief summary

In a previous study in 2012/2013 patients were injected a superparamagnetic iron oxide for sentinel lymph node detection. In this follow up study we want to investigate how much of this tracer is still detectable.

Interventions

PROCEDURENative 1,5 Tesla breast MRI

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

inclusion: * participation in previous study * informed consent * no contraindications for MRI scan exclusion: * contraindications for MRI scan

Design outcomes

Primary

Measure	Time frame	Description
I) Analysis if the supraparamegnetic Tracer is still detectable	04/2017	Analysis by two expert radiologists

Secondary

Measure	Time frame	Description
Analysis to which degree of impairment of Imaging is detected	04/2017	Description as no impairment, impairment, but Interpretation of Images possible, impairment, Image Interpretation impossible

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026